Skip to main content
Article thumbnail
Location of Repository

Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia

By Pavel Drevinek, Adam Baldwin, Christopher G. Dowson and Eshwar Mahenthiralingam


Background: Burkholderia cenocepacia is the most prominent species of the B. cepacia complex (Bcc), a group of nine closely related and difficult to identify bacteria that cause serious infections in patients with cystic fibrosis. Despite its clinical relevance, identification of B. cenocepacia as a single species is unavailable, as it splits by a widely used recA gene-based PCR identification method into discrete phylogenetic subgroups IIIA, IIIB, IIIC and IIID. With the aim of identifying gene targets\ud suitable for unified detection of B. cenocepacia strains, we examined sequence polymorphisms in the repA and parB genes. These essential genes are involved in the replication and partitioning of bacterial replicons, hence we also had the opportunity for the first time to investigate the evolution of the multireplicon (three chromosome) structure of Bcc genomes.\ud Results: Alignment of the repA and parB genes from publicly available Bcc genome sequences enabled the design of primers for their amplification and sequence analysis. Multilocus sequencing typing, a highly discriminatory method for Bcc species and strain discrimination, was used to select strains of unique sequence types (STs) that spanned the known Bcc genetic diversity. Sequence\ud datasets of repA (83 isolates, 67 STs) and parB (120 isolates, 95 STs) genes from the second chromosome were aligned and examined phylogenetically to identify polymorphisms suitable for identification of B. cenocepacia. In contrast to parB, the Bcc repA sequences demonstrated distinct clustering of B. cenocepacia from other species, which enabled the design a species-specific\ud multiplex PCR. The novel single-reaction B. cenocepacia detection method was tested on a panel of 142 different Bcc strains (142 STs) and distinguished recA groups IIIA, IIIB and IIID, from all other Bcc members with 100% sensitivity and 93% specificity.\ud Conclusion: The repA-based multiplex PCR is a useful aid to the rapid identification of the most clinically relevant B. cenocepacia recA subgroups IIIA, IIIB and IIID. Phylogenetic analysis of repA and parB genes demonstrated that acquisition of the second and third replicons of Bcc genomes occurred prior to their differentiation into discrete species and that the sharing of replicons across\ud species had not occurred

Topics: QR
Publisher: BioMed Central Ltd.
Year: 2008
OAI identifier:

Suggested articles


  1. (2004). Bevivino A: Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. doi
  2. (2001). Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
  3. (2001). Burkholderia cepacia genomovar III Is a common plant-associated bacterium. Appl Environ Microbiol doi
  4. (1998). Burkholderia cepacia. Management issues and new insights. Clin Chest Med
  5. (2007). C: Investigating Burkholderia cepacia complex populations recovered from Italian maize rhizosphere by multilocus sequence typing. Environ Microbiol doi
  6. (2007). CG: Environmental Burkholderia cepacia complex isolates in human infection. Emerg Infect Dis doi
  7. (2006). CG: Multilocus sequence typing breathes life into a microbial metagenome. PLoS ONE doi
  8. (2005). CG: Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. doi
  9. (2007). CG: Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis. doi
  10. (2004). CM: Structural flexibility in the Burkholderia mallei genome. doi
  11. (1999). Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.
  12. (2002). Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex.
  13. (1996). Genomic complexity and plasticity of Burkholderia cepacia. doi
  14. (2004). Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. doi
  15. Govan JR: Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. doi
  16. (2003). JR: Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol doi
  17. (1997). Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res doi
  18. (2005). Lipuma JJ: Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. doi
  19. (2000). LiPuma JJ: Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest doi
  20. (2002). Mahenthiralingam E: Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol doi
  21. (2005). Mahenthiralingam E: Development of a recA Gene-Based Identification Approach for the Entire Burkholderia Genus. Appl Environ Microbiol doi
  22. (2001). Mahenthiralingam E: Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. doi
  23. (2005). Mahenthiralingam E: Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic. doi
  24. Molecular Evolutionary Genetics Analysis doi
  25. (2000). P: DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
  26. (2006). ParABS systems of the four replicons of Burkholderia cenocepacia: new chromosome centromeres confer partition specificity. doi
  27. (2002). Pohunek P: Direct PCR Detection of Burkholderia cepacia Complex and Identification of Its Genomovars by Using Sputum as Source of DNA. doi
  28. (2001). S: Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. doi
  29. (2004). Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis. doi
  30. (2000). Speert DP: Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV).
  31. (2001). Speert DP: Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis doi
  32. (2005). The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol doi
  33. (2006). Tiedje JM: Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.